| Home | E-Submission | Sitemap | Editorial Office |  
top_img
    
ORIGINAL ARTICLE
Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them
Background/Aims: There have been numerous efforts to reduce mother-to-child transmission (MTCT) of hepatitis B virus (HBV) with antiviral agents during pregnancy. However, there are limited data regarding the outcomes of pregnant women after delivery. This study was performed to...
ORIGINAL ARTICLE
Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis
Background/Aims: Left ventricular diastolic dysfunction (LVDD) is an early manifestation of cardiac dysfunction in patients with liver cirrhosis (LC). However, the effect of LVDD on survival has not been clarified, especially in decompensated LC. Methods: We prospectively enrol...
CASE REPORT
Bilateral optic neuropathy related to severe anemia in a patient with alcoholic cirrhosis: a case report and review of the literature
Anemia appears frequently in patients with alcoholic liver disease (ALD) but has never been linked to bilateral nonarteritic anterior ischemic optic neuropathy (NAION). A 65-year-old woman with a medical history of alcoholic cirrhosis was admitted for bilateral NAION. On admissi...
ORIGINAL ARTICLE
The Association of leptin with severity of non-alcoholic fatty liver disease: A population-based study
Background/Aims: Leptin is associated with metabolic disorders, which predispose one to non-alcoholic fatty liver disease (NAFLD). The role of leptin in NAFLD pathogenesis is not fully understood. We aim to investigate the association between serum leptin level and severity of N...
Current Issue
Volume 24(4); Dec 2018
Volume 24(3); September 2018
Volume 24(2); June 2018
Volume 24(1); March 2018
Volume 23(4); December 2017
RSS feed
Most-cited are based on citations from 2017 ~ 2019.
Genetic predisposition in nonalcoholic fatty liver disease
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol.2017;23(1):1-12.   Published online March 9, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0109
                                 Cited By 36
Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis
Gaeun Kim, Moon Young Kim, Soon Koo Baik
Clin Mol Hepatol.2017;23(1):34-41.   Published online March 7, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0059
                                 Cited By 16
Radioembolization for the treatment of hepatocellular carcinoma
Hyo-Cheol Kim
Clin Mol Hepatol.2017;23(2):109-114.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0004
                                 Cited By 8
Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function
Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique
Clin Mol Hepatol.2017;23(4):316-322.   Published online August 22, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0087
                                 Cited By 8
Anticoagulation in cirrhosis: a new paradigm?
Filippo Leonardi, Nicola De Maria, Erica Villa
Clin Mol Hepatol.2017;23(1):13-21.   Published online March 14, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0110
                                 Cited By 7
Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study
Byeong Wook Cho, Seok Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae
Clin Mol Hepatol.2017;23(1):51-56.   Published online March 16, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0053
                                 Cited By 7
Epithelioid angiomyolipoma of the liver: a case report
Soo Yeon Lee, Baek-hui Kim
Clin Mol Hepatol.2017;23(1):91-94.   Published online March 17, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0011
                                 Cited By 7
NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs
Stephen Caldwell
Clin Mol Hepatol.2017;23(2):103-108.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0103
                                 Cited By 7
Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system
Tae Kyoung Kim, Seung Yeon Noh, Stephanie R Wilson, Yuko Kono, Fabio Piscaglia, Hyun-Jung Jang, Andrej Lyshchik, Christoph F. Dietrich, Juergen K. Willmann, Alexander Vezeridis, Claude B Sirlin
Clin Mol Hepatol.2017;23(4):280-289.   Published online September 15, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0037
                                 Cited By 7
Current status and strategies for hepatitis B control in Korea
Eun Ju Cho, Sung Eun Kim, Ki Tae Suk, Jihyun An, Soung Won Jeong, Woo Jin Chung, Yoon Jun Kim
Clin Mol Hepatol.2017;23(3):205-211.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0104
                                 Cited By 7
Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma
Edward Wolfgang Lee, Sarah Khan
Clin Mol Hepatol.2017;23(4):265-272.   Published online November 8, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0111
                                 Cited By 7
Microbiota, a key player in alcoholic liver disease
Anne-Marie Cassard, Dragos Ciocan
Clin Mol Hepatol.2018;24(2):100-107.   Published online December 22, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0067
                                 Cited By 7
The use of immunosuppression in autoimmune hepatitis: A current literature review
Angela Cropley, Martin Weltman
Clin Mol Hepatol.2017;23(1):22-26.   Published online March 14, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0089
                                 Cited By 6
Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma
Tae Wook Kang, Hyo Keun Lim, Dong Ik Cha
Clin Mol Hepatol.2017;23(1):95-101.   Published online March 24, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0006
                                 Cited By 6
A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
Hyun Yang, Hyun Young Woo, Soon Kyu Lee, Ji Won Han, Bohyun Jang, Hee Chul Nam, Hae Lim Lee, Sung Won Lee, Do Seon Song, Myeong Jun Song, Jung Suk Oh, Ho Jong Chun, Jeong Won Jang, Angelo Lozada, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clin Mol Hepatol.2017;23(2):128-137.   Published online May 10, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0071
                              Supplementary         Cited By 6
Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik
Clin Mol Hepatol.2017;23(2):170-178.   Published online May 16, 2017     
DOI: https://doi.org/10.3350/cmh.2016.0086
                              Supplementary         Cited By 5
Histopathological evaluation of liver fibrosis and cirrhosis regression
Regina C. Lo, Haeryoung Kim
Clin Mol Hepatol.2017;23(4):302-307.   Published online December 20, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0078
                                 Cited By 5
KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications
The Korean Association for the Study of the Liver (KASL)
Clin Mol Hepatol.2018;24(3):230-277.   Published online July 9, 2018     
DOI: https://doi.org/10.3350/cmh.2018.1005
                              Supplementary         Cited By 5
Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin
Clin Mol Hepatol.2017;23(3):230-238.   Published online June 30, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0003
                                 Cited By 4
Current status of and strategies for hepatitis C control in South Korea
Beom Kyung Kim, Eun Sun Jang, Jeong Han Kim, Soo Young Park, Song Vogue Ahn, Hyung Joon Kim, Do Young Kim
Clin Mol Hepatol.2017;23(3):212-218.   Published online September 19, 2017     
DOI: https://doi.org/10.3350/cmh.2017.0105
                                 Cited By 4
E-Submission
Email Alert
Author's Index
EndNote Style file download
The Korean Association for the Study of the Liver
The Liver Week 2019
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
DOAJ
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
ORCID
MeSH on Demand
COPE
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association for the Study of the Liver. All rights reserved.         
COUNTER
TODAY : 233
TOTAL : 45396